Development of Lansoprazole Sustained-Release Microparticles Using Solvent Evaporation Method
碩士 === 國立臺灣大學 === 藥學研究所 === 96 === Lansoprazole is a proton pump inhibitor which selectively inhibits H+/K+-ATPase. It is usually used for gastric ulcer diseases. However, due to its short half life in plasma, lansoprazole cannot control nocturnal acid breakthrough. This study was aimed to improve t...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2008
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/89328606200515275042 |